Juglanin is a natural compound that functions as a JNK activator, exhibiting anti-inflammatory and anti-tumor properties. Research demonstrates its ability to induce apoptosis and autophagy in human breast cancer cells in vitro, supporting its investigation in oncology and cell signaling studies.